Dedicated to fighting CVD in the ageing population
CVD is the leading cause of morbidity and mortality, with ageing being a primary risk factor. The prevalence of CVD will only further increase due to the ageing of our population. This is particularly relevant for the northern Netherlands, a region with a high prevalence of cardiovascular risk factors and unfavourable socioeconomic circumstances.
Research embedded in care and society
The CVC researchers and physicians are well-embedded in societal organizations, which ensures that the research results are timely implemented in clinical practice and society. Our studies include experimental and clinical research, interventions, and cohort studies.
The CVC researchers conduct intervention studies including pharmacological interventions, lifestyle interventions, and device interventions. In addition, cohort studies are carried out to identify prognostic factors among the general population and populations at high risk of CVD. The role of co-morbidities such as renal disease, cancer, obesity, and diabetes is also examined.
Helping to reduce CVD-related deaths
The CVC translational approach and high-quality research have helped to reduce CVD-related deaths and, therefore, contribute to healthy ageing.